From: Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma
Pathway description | Gene count | p value | FDR | Genes |
---|---|---|---|---|
Mitotic prometaphase | 4 | 2.63E−06 | 3.52E-04 | CEP250,NEK2,MAD1L1,NDC80 |
M phase | 4 | 2.24E−05 | 1.50E-03 | CEP250,NEK2,MAD1L1,NDC80 |
Cell cycle, mitotic | 4 | 9.11E−05 | 4.01E-03 | CEP250,NEK2,MAD1L1,NDC80 |
RHO GTPase effectors | 3 | 3.20E−04 | 0.0106 | MAPK1,MAD1L1,NDC80 |
Opioid signaling | 2 | 7.85E-−04 | 0.0123 | MAPK1,PPP1CA |